TERRE DES FEMMES breaks the silence about domestic violence during what is supposed to be the most peaceful time of the year

Berlin, December 18th 2020: TERRE DES FEMMES – Menschenrechte für die Frau e. V. opens the art exhibition “UNBREAK – take a closer look & break the cycle of domestic violence” (https://cloud.achtung.de/s/g7PanPkDDnf28pe) in downtown Munich, together with the agencies thjnk and achtung! Mary, the artist Simon Berger, and the long-time TERRE DES FEMMES activist Romy… Read More »

People with NNRTI resistance have poorer responses to dolutegravir, South African study finds

People with HIV who already have resistance to a non-nucleoside reverse transcriptase inhibitor (NNRTI) when they start first-line antiretroviral treatment containing the integrase inhibitor dolutegravir were less likely to achieve viral suppression, a large clinical trial in South Africa has reported. NNRTI resistance has not been shown to affect responses to dolutegravir-based treatment previously. The… Read More »

More weight gain in people starting HIV treatment with newer integrase inhibitors or darunavir

A US study has concluded that weight gain is greater by around 2 to 4 kg in HIV-positive people taking bictegravir or dolutegravir as part of their first antiretroviral therapy (ART), compared to their counterparts using other drug regimens. A similar effect was reported in those using the protease inhibitor darunavir. The study led by… Read More »